A detailed history of Sage Rhino Capital LLC transactions in Haleon PLC stock. As of the latest transaction made, Sage Rhino Capital LLC holds 13,087 shares of HLN stock, worth $112,679. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,087
Previous 12,960 0.98%
Holding current value
$112,679
Previous $106,000 4.72%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$8.02 - $8.67 $1,018 - $1,101
127 Added 0.98%
13,087 $111,000
Q4 2023

Feb 05, 2024

SELL
$7.78 - $8.62 $5,749 - $6,370
-739 Reduced 5.39%
12,960 $106,000
Q3 2023

Oct 26, 2023

BUY
$7.85 - $8.94 $6,962 - $7,929
887 Added 6.92%
13,699 $114,000
Q2 2023

Jul 31, 2023

BUY
$8.04 - $9.0 $1,599 - $1,791
199 Added 1.58%
12,812 $107,000
Q1 2023

Apr 20, 2023

BUY
$7.57 - $8.37 $2,800 - $3,096
370 Added 3.02%
12,613 $102,000
Q4 2022

Jan 31, 2023

BUY
$6.08 - $8.06 $74,437 - $98,678
12,243 New
12,243 $97,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $39.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.